% VOLUME OSCILLATOR
Trading: HOLD @ $0.45
Signal Strength: MEDIUM
Cogstate (ASX:CGS) currently has positive PVO 21.07%. The recent volume is gaining momentum through a rise on the short term exponential moving average.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement
The Percentage Volume Oscillator (PVO) is a momentum oscillator for volume. PVO measures the difference between two volume-based moving averages as a percentage of the larger moving average. As with MACD and the Percentage Price Oscillator (PPO) it is shown with a signal line a histogram and a centreline.
Calculation: Percentage Volume Oscillator (PVO):
1) Percentage Volume Oscillator (PVO): ((12-day EMA of Volume - 26-day EMA of Volume)/26-day EMA of Volume) x 100;
2) Signal Line: 9-day EMA of PVO; 3) Histogram: PVO - Signal Line;
PROFILE: Cogstate (CGS.AX)
Stock Exchange: ASX
Ticker Codes: | CGS.AX | ASX:CGS |
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.
% Volume OscillatorDownload
|CTD Corporate Travel Management||28.81||14.7||1,727,133||33.54||BULLISH|
|EMH European Metals Holdings||0.4||14.3||44,010||17.05||BULLISH|
|SVW Seven Holdings||19.02||12.2||2,028,025||14.79||BULLISH|
|AXP Airxpanders Inc||0.04||12.1||4,203,665||26.12||BULLISH|
|GCY Gascoyne Resources||0.11||11.1||1,637,598||0.51||BULLISH|
|AGG Anglogold Ashanti||4.16||8.3||21,558||14.31||BULLISH|